Interferon α decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes

Murao, K.; Imachi, H.; Yu, X.; Cao, W. M.; Nishiuchi, T.; Chen, K.; Li, J.; Ahmed, R. A. M.; Wong, N. C. W.; Ishida, T.
May 2008
Gut;May2008, Vol. 57 Issue 5, p664
Academic Journal
BACKGROUND: Infection with the hepatitis C virus (HCV) causes acute hepatitis. This disease has a high probability of becoming chronic and leading to cirrhosis, but a more deadly consequence is hepatocellular carcinoma. Interferon α (IFN α)-based treatment combined with ribavirin is the major therapeutic choice available for the treatment of chronic HCV infection. AIMS: The scavenger receptor class B type I (SR-BI) or its human homologue CD36 and LIMPII Analogous-1 (hSR-BI/CLA-1) has recently been shown to interact with HCV envelope glycoprotein E2, thus suggesting that it might participate in entry of the virus into host cells. This rationale underlies current interest in the potential role of IFN α in hSR-BI/CLA-1 expression in HepG2 cells. RESULTS: It was shown that endogenous hepatocyte expression of hSR-BI/CLA-1 was suppressed by exposure to IFN α. Decreased hSR-BI/CLA-1 expression in IFN α-treated cells was due to lower transcriptional activity of the promoter. A potential pathway for the effect of IFN α on hSR-BI/CLA-1 promoter activity was identified when the inhibitory action of IFN was abrogated in signal transducer and activator of transcription 1 (STAT1)/STAT2 knocked-down cells. Exposure of HepG2 cells to IFN α elicited a rapid phosphorylation of STAT1/STAT2, a known target of IFN α signalling. In addition, the mutagenesis of a STAT1/STAT2 response element in the hSR-BI/CLA-1 promoter abolished the ability of IFN α to suppress promoter activity. CONCLUSIONS: Together, these results indicate that the STAT1/STAT2 pathway participates in IFN α inhibition of hSR-BI/CLA-1 expression, and raise the possibility that lowering the expression of this gene may be of therapeutic value for treating HCV infections.


Related Articles

  • Hepatitis C virus E2 protein involve in insulin esistance through an impairment of Akt/PKB and GSK3β signaling in hepatocytes. Ming-Ju Hsieh; Kuang-Ping Lan; Hao-Yu Liu; Xiao-Zong Zhang; Yaw-Feng Lin; Tzy-Yen Chen; Hui-Ling Chiou // BMC Gastroenterology;2012, Vol. 12 Issue 1, p74 

    Background: Hepatitis C virus (HCV) infection may cause liver diseases of various severities ranging from primary acute infection to life-threatening diseases, such as cirrhosis or hepatocellular carcinoma with poor prognosis. According to clinical findings, HCV infection may also lead to some...

  • HCV RNA Levels in Serum, Liver, and Peripheral Blood Mononuclear Cells of Chronic Hepatitis C Patients and Their Relationship to Liver Injury. Adinolfi, L. E.; Andreana, A.; Ulili, R.; Zampino, R.; Ragone, E.; Ruggiero, G. // American Journal of Gastroenterology;Nov1998, Vol. 93 Issue 11, p2162 

    Objective: We sought to evaluate the relationship between HCV RNA levels in serum, liver, and peripheral blood mononuclear cells (PBMC) and the degree of liver injury in chronic hepatitis C (CHC) patients. Methods: Thirty-six consecutive CHC patients were included in the study. The liver damage...

  • AST/ALT Ratio Predicts Cirrhosis in Patients With Chronic Hepatitis C Virus Infection. Sheth, Sunil G.; Flamm, Steven L.; Gordon, Fredric D.; Chopra, Sanjiv // American Journal of Gastroenterology;Jan1998, Vol. 93 Issue 1, p44 

    Objective: A liver biopsy is necessary to grade and stage chronic hepatitis C virus (HCV) infection. In a previous study of patients with nonalcoholic liver disease, an aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio > 1 suggested cirrhosis. We sought to examine the...

  • Growth Differentiation Factor 15 Is Induced by Hepatitis C Virus Infection and Regulates Hepatocellular Carcinoma-Related Genes. Youhui Si; Xiuying Liu; Min Cheng; Maorong Wang; Qiaoling Gong; Yang Yang; Tianyi Wang; Wei Yang // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) are commonly induced by chronic hepatitis C virus (HCV) infection. We aimed to identify and characterize the involvement of previously screened cytokine GDF15 in HCV pathogenesis. We examined the GDF15 expression after HCV infection...

  • Hepatitis C Virus Life Cycle and Lipid Metabolism. Popescu, Costin-Ioan; Riva, Laura; Vlaicu, Ovidiu; Farhat, Rayan; Rouillé, Yves; Dubuisson, Jean // Biology (2079-7737);2014, Vol. 3 Issue 4, p892 

    Hepatitis C Virus (HCV) infects over 150 million people worldwide. In most cases HCV infection becomes chronic, causing liver disease ranging from fibrosis to cirrhosis and hepatocellular carcinoma. HCV affects the cholesterol homeostasis and at the molecular level, every step of the virus life...

  • Reducing costs of HCV-related liver disease.  // PharmacoEconomics & Outcomes News;Aug2014, Vol. 709 Issue 1, p7 

    The article discusses research on the costs associated with chronic hepatitis C virus (HCV)-related liver diseases such as cirrhosis, liver failure and hepatocellular carcinoma. The study, which was published in the "Journal of Gastroenterology and Hepatology," revealed that the prevalence of...

  • Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV. Natarajan, Yamini; White, Donna; El-Serag, Hashem; Ramsey, David; Richardson, Peter; Kuzniarek, Jill; Shukla, Richa; Tansel, Aylin; Kanwal, Fasiha; White, Donna L; El-Serag, Hashem B // Digestive Diseases & Sciences;Jan2017, Vol. 62 Issue 1, p76 

    Background: Medical comorbidities and functional status limitations are determinants of mortality in many chronic diseases. The extent to which survival in the rapidly aging cohort of patients with HCV is affected by these competing causes of mortality remains unclear.Aim:...

  • Human oncogenic viruses: Hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Gurtsevitch, V. // Biochemistry (00062979);May2008, Vol. 73 Issue 5, p504 

    Chronic infections caused by hepatitis B virus (HBV) and/or hepatitis C virus (HCV) are the main risk factors for the development of hepatocellular carcinoma (HCC) in humans. Both viruses cause a wide spectrum of clinical manifestations ranging from healthy carrier state to acute and chronic...

  • Peculiarities of development and course of liver cirrhosis complications depending on the etiological factor. Nazyrov, F.G.; Devyatov, A.V.; Babadzanov, A.H.; Raimov, S.A. // Surgery News / Novosti Hirurgii;2013, Vol. 21 Issue 4, p45 

    Objectives. To study the peculiarities of the complications of liver cirrhosis (LC) depending on the etiological factors and to analyze the results of portosystemic shunting (PSSh) in these groups of patients. Methods. The analysis covered the results of the PSSh in 309 cirrhotic patients with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics